Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell

Y Okada1, Y Tsuda, K Wanaka

  • 1Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan. okada@pharm.kobegakuin.ac.jp